LifeMD, Inc. LFMD
1.45 USD -0.15 (-9.40%)
Regular-session close
1.45 0.00 +0.35%
After hours · Nov 20, 7:37 PM ET
1.38 Day range 1.58
1.38 52-week range 5.38
- YTD
- -57.62%
- 1 year
- -61.05%
News
benzinga.com HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $6 HC Wainwright & Co. analyst Yi Chen maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $9 to $6.
fool.com LifeMD: 3 Key Takeaways for Long-Term Investors LifeMD partnered with Eli Lilly and Novo Nordisk for direct GLP-1 fulfillment. AT&T collaboration grants 100 million customers free LifeMD virtual healthcare access.benzinga.com Lake Street Maintains Buy on LifeMD, Lowers Price Target to $3 Lake Street analyst Ryan Meyers maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $5 to $3.
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers Cerenome (NASDAQ:CNSY) shares rose 39.5% to $1.07 during Friday's regular session. The market value of their outstanding shares is at $5.8 million. As per the press release, Q3 earnings came…benzinga.com Mizuho Maintains Outperform on LifeMD, Lowers Price Target to $6 Mizuho analyst Steven Valiquette maintains LifeMD (NASDAQ:LFMD) with a Outperform and lowers the price target from $7 to $6.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers SELLAS Life Sciences Gr (NASDAQ:SLS) stock rose 19.6% to $9.6 during Friday's pre-market session. The market value of their outstanding shares is at $1.6 billion. As per the news, the Q3…
seekingalpha.com LifeMD, Inc. (LFMD) Q3 2026 Earnings Call Transcript LifeMD, Inc. (LFMD) Q3 2026 Earnings Call Transcriptbenzinga.com LifeMD Q3 EPS $(0.11) Beats $(0.14) Estimate, Sales $44.625M Miss $48.885M Estimate LifeMD (NASDAQ:LFMD) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 57.14 percent decrease over losses of $(0.07) per…
benzinga.com LifeMD Lowers FY2026 Sales Guidance from $205.500M-$212.500M to $188.000M-$191.000M vs $207.582M Est LifeMD (NASDAQ:LFMD) lowers FY2026 sales outlook from $205.500 million-$212.500 million to $188.000 million-$191.000 million vs $207.582 million estimate.
benzinga.com LifeMD Announces Agreement For Its Pharmacies To Directly Dispense, Ship Eli Lilly's Self-Pay GLP-1 Medicines LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced an arrangement with Eli Lilly and Company (Lilly) that enables LifeMD's affiliated pharmacy to directly…
